LncRNA XIST accelerates the progression of OSAHS disease by reducing the expression of glucocorticoid receptor α (GRα) and activating the NF-кB-dependent signaling pathway (Zhou et al., 2021). Here, NR3C1 is linked to obstructive sleep apnea syndrome.